Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase II Clinical Trial

被引：0
|
作者：
Yang, Chuting [1 ]
Zheng, Yaling [1 ]
Song, Chaoyang [2 ]
Wu, Ming [1 ]
Wang, Lei [1 ]
Zhou, Xuan [1 ]
Yue, Chunyan [1 ]
Lin, Xiaonan [1 ]
Chen, Jie [3 ]
Zeng, Hui [3 ]
Huang, Rui [1 ]
Li, Yuhua [2 ]
机构：
[1] Southern Med Univ, Dept Hematol, Zhujiang Hosp, Guangzhou, Peoples R China
[2] Southern Med Univ, Zhujiang Hosp, Dept Hematol, Guangzhou, Peoples R China
[3] Jinan Univ, Dept Hematol, Affiliated Hosp 1, Guangzhou, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-174879
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Maintenance Therapy with Chidamide Plus Azacitidine after Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Acute Myeloid Leukemia Patients
    Hu, Xiaohui
    Wu, Depei
    Chen, Suning
    Wu, Yaxue
    Zhang, Yang
    Bai, Lian
    Wu, Bing
    Zhou, Haixia
    Xu, Mingzhu
    Jiang, Shanshan
    Qian, Chongsheng
    Xue, Shengli
    BLOOD, 2023, 142
  • [2] Prospective Evaluation of Azacitidine Maintenance Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Gill, Harinder
    Lie, Albert Kwok Wai
    Kwong, Yok Lam
    Leung, Anskar Y. H.
    BLOOD, 2015, 126 (23)
  • [3] Low-dose azacitidine maintenance therapy after allogeneic stem cell transplantation for high-risk pediatric acute myeloid leukemia
    Tamura, Akihiro
    Ishida, Toshiaki
    Saito, Atsuro
    Yamamoto, Nobuyuki
    Yokoi, Takehito
    Uemura, Suguru
    Nino, Nanako
    Fujiwara, Takahiro
    Tahara, Teppei
    Nakamura, Sayaka
    Kozaki, Aiko
    Kishimoto, Kenji
    Hasegawa, Daiichiro
    Kosaka, Yoshiyuki
    PEDIATRIC BLOOD & CANCER, 2018, 65 (10)
  • [4] Low-dose decitabine as maintenance after allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia
    Bucalossi, Alessandro
    Tozzi, Monica
    Lenoci, Mariapia
    Toraldo, Francesca
    Del Re, Valeria
    Marotta, Giuseppe
    BONE MARROW TRANSPLANTATION, 2019, 54 : 170 - 170
  • [5] Maintenance therapy with decitabine after allogeneic hematopoietic stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia
    Ma, Yunju
    Qu, Changju
    Dai, Haiping
    Yin, Jia
    Li, Zheng
    Chen, Jia
    Qiu, Huiying
    Sun, Aining
    Miao, Miao
    Fu, Chengcheng
    Jin, Zhengming
    Zhu, Xiaming
    Wu, Depei
    Tang, Xiaowen
    BONE MARROW TRANSPLANTATION, 2020, 55 (06) : 1206 - 1208
  • [6] Azacitidine for relapse of acute myeloid leukemia or myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation, multicenter PALG analysis
    Drozd-Sokolowska, Joanna
    Karakulska-Prystupiuk, Ewa
    Biecek, Przemyslaw
    Kobylinska, Katarzyna
    Piekarska, Agnieszka
    Dutka, Magdalena
    Waszczuk-Gajda, Anna
    Madry, Krzysztof
    Kopinska, Anna
    Golos, Aleksandra
    Gora-Tybor, Joanna
    Szwedyk, Pawel
    Bolkun, Lukasz
    Czyz, Anna
    Giebel, Sebastian
    Basak, Grzegorz Wladyslaw
    Dwilewicz-Trojaczek, Jadwiga
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (01) : 129 - 136
  • [7] Maintenance therapy with decitabine after allogeneic hematopoietic stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia
    Yunju Ma
    Changju Qu
    Haiping Dai
    Jia Yin
    Zheng Li
    Jia Chen
    Huiying Qiu
    Aining Sun
    Miao Miao
    Chengcheng Fu
    Zhengming Jin
    Xiaming Zhu
    Depei Wu
    Xiaowen Tang
    Bone Marrow Transplantation, 2020, 55 : 1206 - 1208
  • [8] Azacitidine maintenance after allogeneic stem cell transplantation is feasible in patients with acute myeloid leukemia and myelodysplasia
    Antar, A.
    Kharfan-Dabaja, M.
    Abou Ghaddara, H.
    Mahfouz, R.
    Bazarbachi, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S258 - S258
  • [9] Azacitidine Maintenance after Allogeneic Stem Cell Transplantation Is Feasible in Patients with Acute Myeloid Leukemia and Myelodysplasia
    Antar, Ahmad
    Kharfan-Dabaja, Mohamed A.
    Abou Ghaddara, Hussein
    Mahfouz, Rami
    Bazarbachi, Ali
    BLOOD, 2014, 124 (21)
  • [10] Chidamide with Azacitidine and CHOP Treatment Plus Autologous Transplantation,Followed By Maintenance with Chidamide for Patients with Newly Diagnosed Peripheral T-Cell Lymphoma: Interim Analysis of a Prospective,Single Center,Single-Arm, Phase 2 Trial
    Xiao, Chunyan
    Ding, Yao
    Zeng, Chensi
    Zhang, Lingqian
    Guo, Bingling
    Nan, Yingyu
    Liu, Yao
    BLOOD, 2023, 142
12345